-
Je něco špatně v tomto záznamu ?
Cognitive changes in spinocerebellar ataxia type 2
M. Valis, J. Masopust, J. Bažant, Z. Ríhová, D. Kalnická, A. Urban, A. Zumrová, J. Hort,
Jazyk angličtina Země Švédsko
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
21712788
Knihovny.cz E-zdroje
- MeSH
- dospělí MeSH
- exekutivní funkce MeSH
- kognice fyziologie MeSH
- kognitivní poruchy etiologie psychologie MeSH
- lidé středního věku MeSH
- lidé MeSH
- neuropsychologické testy MeSH
- paměť fyziologie MeSH
- pozornost fyziologie MeSH
- psychomotorický výkon fyziologie MeSH
- spinocerebelární ataxie komplikace genetika psychologie MeSH
- učení fyziologie MeSH
- věk při počátku nemoci MeSH
- zraková percepce fyziologie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
OBJECTIVES: Cognitive disorders and dementia occur in 19 to 42% of patients with spinocerebellar ataxia type 2 (SCA2). Neuropsychological tests can reveal executive dysfunction, impaired visual and verbal memory, tongue and speech impairment, attention disorders and impaired verbal fluency. METHODS: We performed psychiatric and neuropsychological examinations in 12 patients diagnosed with genetically confirmed SCA2 and 12 healthy volunteers matching the patients in age, gender, and length of education. The level of motor impairment was determined using the brief ataxia rating scale (BARS). The neuropsychological examination focused on testing executive functions, short-term visual and verbal memory, attention, psychomotor tempo, visual motor coordination, learning ability and comprehension ability. The tests were divided into two subgroups according to the difficulty of motor tasks. The cognitive abilities composite score (CACS) was determined by calculating the arithmetic mean of T scores of the respective tests. RESULTS: Patients with SCA2 had significantly lower CACSs (p=0.00005) compared to the healthy volunteers. Patients exhibited impaired performance in both difficult and simple motor tests. The severity of cognitive impairment was related to the age at the onset of the disease (p=0.002) but not to the duration or to the overall BARS score. CONCLUSIONS: Compared to healthy volunteers, patients with SCA2 exhibited significantly worse cognitive performance in all areas tested, including the tests of simple motor tasks. Moreover, the cognitive performance of patients worsened as the difficulty of the motor tasks increased.
- 000
- 00000naa a2200000 a 4500
- 001
- bmc12027478
- 003
- CZ-PrNML
- 005
- 20121210095542.0
- 007
- ta
- 008
- 120817s2011 sw f 000 0#eng||
- 009
- AR
- 035 __
- $a (PubMed)21712788
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a sw
- 100 1_
- $a Valis, Martin $u Department of Neurology, Charles University, Faculty of Medicine and University Hospital in Hradec Králové, Czech Republic. valismar@seznam.cz
- 245 10
- $a Cognitive changes in spinocerebellar ataxia type 2 / $c M. Valis, J. Masopust, J. Bažant, Z. Ríhová, D. Kalnická, A. Urban, A. Zumrová, J. Hort,
- 520 9_
- $a OBJECTIVES: Cognitive disorders and dementia occur in 19 to 42% of patients with spinocerebellar ataxia type 2 (SCA2). Neuropsychological tests can reveal executive dysfunction, impaired visual and verbal memory, tongue and speech impairment, attention disorders and impaired verbal fluency. METHODS: We performed psychiatric and neuropsychological examinations in 12 patients diagnosed with genetically confirmed SCA2 and 12 healthy volunteers matching the patients in age, gender, and length of education. The level of motor impairment was determined using the brief ataxia rating scale (BARS). The neuropsychological examination focused on testing executive functions, short-term visual and verbal memory, attention, psychomotor tempo, visual motor coordination, learning ability and comprehension ability. The tests were divided into two subgroups according to the difficulty of motor tasks. The cognitive abilities composite score (CACS) was determined by calculating the arithmetic mean of T scores of the respective tests. RESULTS: Patients with SCA2 had significantly lower CACSs (p=0.00005) compared to the healthy volunteers. Patients exhibited impaired performance in both difficult and simple motor tests. The severity of cognitive impairment was related to the age at the onset of the disease (p=0.002) but not to the duration or to the overall BARS score. CONCLUSIONS: Compared to healthy volunteers, patients with SCA2 exhibited significantly worse cognitive performance in all areas tested, including the tests of simple motor tasks. Moreover, the cognitive performance of patients worsened as the difficulty of the motor tasks increased.
- 650 _2
- $a dospělí $7 D000328
- 650 _2
- $a věk při počátku nemoci $7 D017668
- 650 _2
- $a pozornost $x fyziologie $7 D001288
- 650 _2
- $a kognice $x fyziologie $7 D003071
- 650 _2
- $a kognitivní poruchy $x etiologie $x psychologie $7 D003072
- 650 _2
- $a exekutivní funkce $7 D056344
- 650 _2
- $a ženské pohlaví $7 D005260
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a učení $x fyziologie $7 D007858
- 650 _2
- $a mužské pohlaví $7 D008297
- 650 _2
- $a paměť $x fyziologie $7 D008568
- 650 _2
- $a lidé středního věku $7 D008875
- 650 _2
- $a neuropsychologické testy $7 D009483
- 650 _2
- $a psychomotorický výkon $x fyziologie $7 D011597
- 650 _2
- $a spinocerebelární ataxie $x komplikace $x genetika $x psychologie $7 D020754
- 650 _2
- $a zraková percepce $x fyziologie $7 D014796
- 655 _2
- $a časopisecké články $7 D016428
- 655 _2
- $a práce podpořená grantem $7 D013485
- 700 1_
- $a Masopust, Jirí
- 700 1_
- $a Bažant, Jan
- 700 1_
- $a Ríhová, Zuzana
- 700 1_
- $a Kalnická, Dita
- 700 1_
- $a Urban, Aleš
- 700 1_
- $a Zumrová, Alena
- 700 1_
- $a Hort, Jakub
- 773 0_
- $w MED00168352 $t Neuro endocrinology letters $x 0172-780X $g Roč. 32, č. 3 (2011), s. 354-9
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/21712788 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y m
- 990 __
- $a 20120817 $b ABA008
- 991 __
- $a 20121210095619 $b ABA008
- 999 __
- $a ok $b bmc $g 949520 $s 784824
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2011 $b 32 $c 3 $d 354-9 $i 0172-780X $m Neuro-endocrinology letters $n Neuro-endocrinol. lett. $x MED00168352
- LZP __
- $a Pubmed-20120817/11/03